Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema

Vascular Pharmacology

Volumn 49, Issue 1, 2008, Pages 44-50

  Liu, Yanli ^a   Fang, Yunhai ^b   Dong, Ping ^c   Gao, Jie ^d   Liu, Rong ^a   Tian, Hua ^a   Ding, Zhaoxi ^a   Bi, Yushun ^a   Liu, Zhiyu ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Blood Center of Shandong Province   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Rat; Secondary lymphedema; VEGF C

Indexed keywords

PLASMID DNA; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; GENE TRANSFER; HINDLIMB; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; LYMPHEDEMA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; VOLUMETRY; WISTAR RAT;

ANIMALS; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; HINDLIMB; LYMPHEDEMA; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 46649092288     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.05.003     Document Type: Article

References (30)

1. Bobek V., Taltynov O., Pinterova D., and Kolostova K. Gene therapy of the ischemic lower limb - therapeutic angiogenesis. Vasc. Pharmacol. 44 (2006) 395-405
2. Chu K., Kang D.-W., Kim H.-J., Lee Y.-S., and Park S.-H. Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema?. Arch. Neurol. 59 (2002) 123
3. Enholm B., Karpanen T., Jeltsch M., Kubo H., Stenback F., Prevo R., Jackson D.G., Yla-Herttuala S., and Alitalo K. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88 (2001) 623-629
4. Gao J., Liu Z., Dong P., Bi Y., Tian H., Li B., and Song T. Construction of eukaryotic vector for human vascular endothelial growth factor C gene. J. Shanghai Jiaotong Univ. (Health Sciences) 41 2 (2003) 151-154
5. Hiltunen M.O., Laitinen M., Turunen M.P., Jeltsch M., Hartikainen J., Rissanen T.T., Laukkanen J., Niemi M., Kossila M., Hakkinen T.P., Kivelä A., Enholm B., Mansukoski H., Turunen A.M., Alitalo K., and Yla-Herttuala S. Intravascular adenovirus-mediated VEGF-C transfer reduces neointima formation in balloon-denuded aorta. Circulation 102 (2000) 2262-2268
6. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423
7. Joukov V., Sorsa T., Kumar V., Jeltsch M., Claesson-Welsh L., Cao Y., Saksela O., Kalkkinen N., and Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16 (1997) 3898-3911
8. Jussila L., and Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82 (2002) 673-700
9. Kanter M.A., Slavin S.A., and Kaplan W. An experimental model for chronic lymphedema. Plast. Reconstr. Surg. 85 4 (1990) 573-580
10. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., Alitalo K., and Finegold D.N. Missense mutation interfere with VEGFR-3 signalling in primary lympoedema. Nat. Genet. 25 (2000) 153-159
11. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., Betsholtz C., and Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 1 (2004) 74-80
12. Karpanen T., and Alitalo K. Lymphatic vessels as targets of tumor therapy?. J. Exp. Med. 194 (2001) F37-F42
13. Karpanen T., Wirzenius M., Makinen T., Veikkola T., Haisma H.J., Achen M.G., Stacker S.A., and Pytowski B. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 169 (2006) 708-718
14. Lee-Donaldson L., et al. Refinement of a rodent model of peripheral lymphedema. Lymphology 32 (1999) 111-117
15. Lette J. A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer. J. Clin. Oncol. 24 (2006) 5434-5440
16. Makinen T., Veikkola T., and Mustjoki S. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20 17 (2001) 4762-4773
17. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., et al. Vascular endothelial growth factor C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20 (2001) 672-682
18. Olofsson B., Jeltsch M., Eriksson U., and Alitalo K. Current biology of VEGF-B and VEGF-C. Curr. Opin. Biotechnol. 10 (1999) 528-535
19. Pain S.J., and Purushotham A.D. Lymphoedema following surgery for breast cancer. Br. J. Surg. 87 (2000) 1128-1141
20. Partanen T., Arola J., Saaristo A., Jussila L., Ora A., Miettinen M., Stacker S., Achen M., and Alitalo K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 14 (2000) 2087-2096
21. Prevo R., Jackson D.G., Yla-Herttuala S., Alitalo K., Enholm B., Karpanen T., Jeltsch M., Kubo H., and Stenback F. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88 (2001) 623-629
22. Rockson S.G. Lymphedema. Am. J. Med. 110 (2001) 288-295
23. Saaristo A., Tammela T., Timonen J., Yla-Herttuala S., Tukiainen E., Asko-Seljavaara S., and Alitalo K. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. (2004) 10.1096/fj.04-1592fje
24. Saito Y., Nakagami H., Morishita R., Takami Y., Kikuchi Y., Hayashi H., and Nishikawa T. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 114 (2006) 1177-1184
25. Stacker S.A., Stenvers K., Caesar C., Vitali A., Domagala T., Nice E., Roufail S., Simpson R.J., Moritz R., Karpanen T., Alitalo K., and Achen M.G. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274 (1999) 32127-32136
26. Szuba A., Skobe M., Karkkainen M.J., Shin W.S., Beynet D.P., Rockson N.B., Dakhil N., Spilman S., Goris M.L., Strauss H.W., Quertermous T., Alitalo K., and Rockson S.G. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16 (2002) 1985-1987
27. Taylor R., Jayasinghe U.W., Koelmeyer L., Ung O., and Boyages J. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys. Ther. 86 (2006) 205-214
28. Witte M.H., Bernas M.J., Martin C.P., and Witte C.L. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Tech. 55 (2001) 122-145
29. Witzenbichler B., Asahara T., Murohara T., Silver M., Spyridopoulos I., Magner M., Principe N., Kearney M., Hu J.-S., and Isner J.M. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153 (1998) 381
30. Yoon Y.-s., Murayama T., Gravereaux E., Tkebuchava T., Silver M., Curry C., and Wecker A. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111 (2003) 717